₹173.4 crore for the June quarter of the current financial year (Q1FY24) against a profit of ₹323.9 crore in the same quarter last year. Revenue from operations, however, rose 16.4 per cent YoY to ₹4,417.8 crore against ₹3,795.6 crore in Q1FY23. Consolidated EBITDA excluding 24/7 operating cost and ESOP charge stood at ₹712.9 crore, up 13 per cent YoY, the company said in a BSE filing.
Segment-wise, healthcare services revenue grew to ₹2,293.7 crore, rising 13 per cent YoY growth while Healthco revenues grew to ₹1,805.4 crore, up 22 per cent YoY growth and, as per the company, is on track for break even in Q4FY24. "We have witnessed healthy growth and performance in the first quarter of the fiscal year 2024. Apollo Hospitals remains dedicated to advancing healthcare excellence, embracing innovation, and expanding our reach to provide quality medical services to even more communities," said Dr.
Prathap C Reddy, Chairman of Apollo Hospitals Group. The company highlighted it is using AI (artificial intelligence) across the healthcare spectrum which is a remarkable fusion of technology and human touch in the healthcare space. "The escalating global challenge of non-communicable diseases (NCDs) continues to put at risk the health of communities at large.
We are determined to face this challenge head-on, bolstered by our commitment to technology-led healthcare. At Apollo, we have harnessed AI as a powerful ally to make it an integral part of our healthcare ecosystem," said Reddy. "With tools like the AI CVD, AI-enabled Apollo ProHealth platform, the Apollo Clinical Intelligence Engine (Apollo CIE), AI-integrated radiology and diagnostics workflow, and the AI-powered smart in-patient room automation system, we are using AI
. Read more on livemint.com